Cargando…

Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with serious adverse outcomes, including heart failure, arrhythmias, and sudden cardiac death. The discovery that mutations in sarcomere protein genes cause HCM has enabled the development of mouse models that recapitulate clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teekakirikul, Polakit, Padera, Robert F., Seidman, J.G., Seidman, Christine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2012
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483129/ https://www.ncbi.nlm.nih.gov/pubmed/23109667 http://dx.doi.org/10.1083/jcb.201207033

Ejemplares similares

Hypertrophic Cardiomyopathy: What’s a Few Millimeters Among Friends?
por: Teekakirikul, Polakit, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
por: Teekakirikul, Polakit, et al.
Publicado: (2019)

Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
por: Bos, J. Martijn, et al.
Publicado: (2020)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
por: Alamo, Lorenzo, et al.
Publicado: (2017)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Margara, Francesca, et al.
Publicado: (2022)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
por: Reichart, Daniel, et al.
Publicado: (2023)

Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
por: Fahed, Akl C., et al.
Publicado: (2020)

The Role of the L-Type Ca(2+) Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic Cardiomyopathy
por: Viola, Helena M., et al.
Publicado: (2016)

Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation–Contraction Coupling
por: Moore, Jarrod, et al.
Publicado: (2023)

Translational investigation of electrophysiology in hypertrophic cardiomyopathy
por: Flenner, Frederik, et al.
Publicado: (2021)

Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model
por: Axelsson Raja, Anna, et al.
Publicado: (2022)

Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies
por: Fish, Maryam, et al.
Publicado: (2016)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Dynamic Cellular Integration Drives Functional Assembly of the Heart’s Pacemaker Complex
por: Bressan, Michael, et al.
Publicado: (2018)

Corrigendum: Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies
por: Fish, Maryam, et al.
Publicado: (2016)

Preventative therapeutic approaches for hypertrophic cardiomyopathy
por: Solomon, Tanya, et al.
Publicado: (2020)

Integrins talk to N-cadherin
por: LeBrasseur, Nicole
Publicado: (2004)

The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication
por: Harris, Stephanie, et al.
Publicado: (2019)

Rare and Common Variants Uncover the Role of the Atria in Coarctation of the Aorta
por: Zhu, Wenjuan, et al.
Publicado: (2022)

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere
por: Agarwal, Radhika, et al.
Publicado: (2022)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Why doesn’t sleep advice talk about sex?
por: Rackal, Yuliya
Publicado: (2021)

Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
por: Captur, Gaby, et al.
Publicado: (2014)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Curcumin hormesis mediates a cross-talk between autophagy and cell death
por: Rainey, N, et al.
Publicado: (2015)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Whole-Genome Sequencing as a First-Line Genetic Test in Familial Dilated Cardiomyopathy
por: Minoche, Andre E., et al.
Publicado: (2018)

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
por: Sharpe, Ashley N., et al.
Publicado: (2023)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
por: Alcalai, Ronny, et al.
Publicado: (2021)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

Talk of the Towns
Publicado: (1998)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

High-Throughput Phenotyping Toolkit for Characterizing Cellular Models of Hypertrophic Cardiomyopathy In Vitro
por: Mosqueira, Diogo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ohrvnu16l1j4ig4h7at3fq51rn